Name and Educational Degree: Kerns, William, DVM, MS Certifications Diplomate, American College of Veterinary Pathologists Education DVM: Ohio State University-1975 MS: Ohio State University-1976 DACVP-1980     Business Address: Aptuit Consulting Inc. 91 Hartwell Ave. Lexington, MA 02421 USA Contact Information: Telephone: 978 456 9975 Email Address: bill.kerns@aptuit.com Web Site URL: http://www.aptuitconsulting.com Specialties Managing Drug Development (API thru Phase 2);;Cardiovascular Pharmacology, Toxicology, Pathology;;Expert Witness Experience Dr. Kerns has 25 years of experience in Pharmaceutical Research and Development having held senior executive positions in Preclinical Development at SmithKlineFrench, SmithKlineBeecham and Eisai Pharma during his pharmaceutical career.   In 2001, he started Pharma Consulting Inc. (PCI), a successful global consulting practice focused on assisting biopharmaceutical companies in drug development and regulatory strategy from manufacturing through early Phase 2.  His has worked with companies in all major markets and all disease areas.  In 2006, PCI merged with Aptuit Consulting Inc.(ACI). Dr. Kerns is Managing Director of ACI.  Aptuit Consulting brings a wealth of pharmaceutical drug development and litigation experience to meet the needs of the biopharmaceutical industry. Dr. Kerns is recognized as an expert in Drug Development and Safety Assessment with a focus on mechanisms of drug-induced cardiovascular toxicity.  He has been involved in submitting over 100 INDs and 16 NDA/MAA to international authorities and the FDA.  Dr. Kerns has authored or co-authored over 100 articles, chapters and abstracts and co-edited a book on cardiovascular toxicology.  He has also been actively involved in the SOT, STP and ACVP, and he has co-chaired an FDA expert committee on biomarkers of drug-induced vascular injury.   << Back to Index of Consultants